Exact Mass: 510.3193

Exact Mass Matches: 510.3193

Found 481 metabolites which its exact mass value is equals to given mass value 510.3193, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ganodermic acid TQ

(2E)-6-[12-(acetyloxy)-2,6,6,11,15-pentamethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),9-dien-14-yl]-2-methylhept-2-enoic acid

C32H46O5 (510.3345)

Ganodermic acid TQ is found in mushrooms. Ganodermic acid TQ is a metabolite of Ganoderma lucidum (reishi).

LysoPG(18:1(9Z)/0:0)

[(2S)-2,3-dihydroxypropoxy][(2R)-2-hydroxy-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid

C24H47O9P (510.2958)

LysoPG(18:1(9Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:1(9Z)/0:0), in particular, consists of one chain of oleic acid at the C-1 position.

(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

C29H38N2O6 (510.273)

Dodecyl-beta-D-maltoside

2-{[6-(dodecyloxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C24H46O11 (510.304)

alpha-Tocopherol phosphate

{[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl]oxy}phosphonic acid

C29H51O5P (510.3474)

(S)-4-[(S)-2-((S)-1-Formyl-4-guanidino-butylcarbamoyl)-pyrrolidin-1-yl]-4-oxo-3-(2-propyl-pentanoylamino)-butyric acid methyl ester

N-(5-Carbamimidamido-1-oxopentan-2-yl)-1-{2-[(1-hydroxy-2-propylpentylidene)amino]-4-methoxy-4-oxobutanoyl}pyrrolidine-2-carboximidate

C24H42N6O6 (510.3166)

Cymegesolate

(17-Acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl) 3-cyclopentylpropanoate

C32H46O5 (510.3345)

[1R-[1alpha(E),4beta,4abeta,5beta(E),6alpha,8aalpha]]-[4-(Acetyloxy)decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-2,4-pentadienyl)-1-naphthalenyl]methyl ester 3-(4-hydroxyphenyl)-2-propenoic acid

C31H42O6 (510.2981)

Paxillosterone

2beta,3beta,11alpha,14alpha,20R,22R,24-heptahydroxy-5beta-ergosta-7-en-6-one

C31H42O6 (510.2981)

euphoractin K

C31H42O6 (510.2981)

(2α,3β,5α,17β)-17-(1-methoxyethoxy)-17-methylandrostane-2,3-diol 3(β-δ-digitoxopyranoside)|(2α,3β,5δ,17β)-2-hydroxy-17-(1-methoxyethoxy)-17-methylandrostan-3-yl 2,5-dideoxy-D-ribo-hexopyranoside

11-(3-acetoxy-1-propynyl)-1α,25-dihydroxy-9,11-didehydrovitamin D3 / 11-(3-acetoxy-1-propynyl)-1α,25-dihydroxy-9,11-didehydrocholecalciferol

C32H46O5 (510.3345)

ZK 168281

(5Z,7E,22E)-(1S,3R,24R)-25-(carboethoxy-methylene)-26,26-cyclo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol

n-Dodecyl-beta-D-maltoside

C24H46O11 (510.304)

D013501 - Surface-Active Agents > D003902 - Detergents

n-Dodecyl α-D-maltoside

Dodecyl-alpha-D-maltoside

C24H46O11 (510.304)

carbanide,(2R,5R)-1-cyclopentyl-2,5-diethylphospholane,iron(2+)

C28H56FeP2 (510.3206)

D,L-threo-PPMP

C29H51ClN2O3 (510.3588)

Fmoc-L-Lys(Boc,iPr)-OH

C29H38N2O6 (510.273)

Boc-Glu(OcHex)-OH·DCHA

C28H50N2O6 (510.3669)

Ethyl acrylate-acrylic acid-2-ethylhexyl acrylate-N-methylolacrylamide-acrylonitrile polymer

C26H42N2O8 (510.2941)

Atrasentan

C29H38N2O6 (510.273)

C28313 - Endothelin Receptor Antagonist > C28334 - Endothelin Receptor Type A Antagonist D065128 - Endothelin Receptor Antagonists > D065130 - Endothelin A Receptor Antagonists D000970 - Antineoplastic Agents

Bis(tri-t-butylphosphine)palladium

C24H54P2Pd (510.2735)

4-Hydroxy-2,2,6,6-tetramethyl-piperidinooxy sebacate

C28H50N2O6 (510.3669)

N-(butoxymethyl)prop-2-enamide,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile,2-methylprop-2-enoic acid

C26H42N2O8 (510.2941)

3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane

C31H46N2O4 (510.3457)

3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl dihydrogen phosphate

C29H51O5P (510.3474)

2,3,14-trihydroxy-10,13-dimethyl-17-(2,3,6,7-tetrahydroxy-5,6-dimethylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one

C28H46O8 (510.3193)

(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

C29H38N2O6 (510.273)

(S)-4-[(S)-2-((S)-1-Formyl-4-guanidino-butylcarbamoyl)-pyrrolidin-1-yl]-4-oxo-3-(2-propyl-pentanoylamino)-butyric acid methyl ester

N-(5-Carbamimidamido-1-oxopentan-2-yl)-1-{2-[(1-hydroxy-2-propylpentylidene)amino]-4-methoxy-4-oxobutanoyl}pyrrolidine-2-carboximidate

C24H42N6O6 (510.3166)

Narbomycin(1+)

C28H48NO7+ (510.3431)

An organic cation that is the conjugate acid of pikromycin, obtained by protonation of the tertiary amino group; major species at pH 7.3.

Heptadecanoyllysophosphatidylcholine

C25H53NO7P+ (510.3559)

(5R)-2,5,6-trihydroxy-2-methyl-6-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

C27H42O9 (510.2829)

[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl] 22-hydroxydocosanoate

C25H51O8P (510.3321)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-octadec-11-enoate

C24H47O9P (510.2958)

Longirostrerone B

2-[(3-Decoxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H53NO7P+ (510.3559)

1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-sn-glycerol)

C24H47O9P (510.2958)

(5Z,7E,22E)-(1S,3R,24R)-25-(carboethoxy-methylene)-26,26-cyclo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol

5-{[7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-6-(2-methylbutanoyl)-5-oxochromen-8-yl]methyl}-2,6-dimethylhepta-2,6-dienoic acid

C31H42O6 (510.2981)

(2'r,4's,6'r,8''r)-5''-(2-hydroxyethyl)-2',8''-bis(hydroxymethyl)-4'-methoxy-2',4',6'',8''-tetramethyl-1',3',3'',4'',7'',9''-hexahydrodispiro[cyclopropane-1,5'-indene-6',2''-indeno[4,5-b]pyran]-7'-one

(2'r,4's,6'r,8''r)-5''-(2-hydroxyethyl)-2',8''-bis(hydroxymethyl)-4'-methoxy-2',4',6'',8''-tetramethyl-1',3',3'',4'',7'',9''-hexahydrodispiro[cyclopropane-1,5'-indene-6',2''-indeno[4,5-b]pyran]-7'-one

C31H42O6 (510.2981)

(3e,5e,7s,8r,10s,15r,16z,18z,24s)-11-ethyl-7,20,24,27,28-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one

C29H38N2O6 (510.273)

(1e,3z,5z,7s,8r,9s,10s,11s,13r,15s,16z,18z,24s,25s)-11-ethyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one

C29H38N2O6 (510.273)

[(1r,4r,4as,5r,6r,8as)-4-(acetyloxy)-6-hydroxy-1,4a,6-trimethyl-5-[(2e)-3-methylpenta-2,4-dien-1-yl]-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C31H42O6 (510.2981)

(5s,6s)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C32H46O5 (510.3345)

20-hydroxy 24-hydroxymethyl ecdysone

C28H46O8 (510.3193)

{"Ingredient_id": "HBIN003408","Ingredient_name": "20-hydroxy 24-hydroxymethyl ecdysone","Alias": "NA","Ingredient_formula": "C28H46O8","Ingredient_Smile": "CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CC(CO)C(C)(C)O)O)O)O","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10203","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129716312","DrugBank_id": "NA"}

6-hydroxythiobinupharidine

C30H42N2O3S (510.2916)

{"Ingredient_id": "HBIN012470","Ingredient_name": "6-hydroxythiobinupharidine","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19420;19421;19422","PubChem_id": "9936153","DrugBank_id": "NA"}

6-hydroxythionuphlutine b

C30H42N2O3S (510.2916)

{"Ingredient_id": "HBIN012471","Ingredient_name": "6-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19424;19425;19426","PubChem_id": "10984042","DrugBank_id": "NA"}

6'-hydroxythionuphlutine b

C30H42N2O3S (510.2916)

{"Ingredient_id": "HBIN012472","Ingredient_name": "6'-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)CS3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19423","PubChem_id": "10164525","DrugBank_id": "NA"}

(1s,3as,5as,6r,7s,8s,9ar,9bs,11ar)-3a,6,7,8-tetrahydroxy-9a,11a-dimethyl-1-[(2r,3r,5s)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C28H46O8 (510.3193)

3a,7,8-trihydroxy-9a,11a-dimethyl-1-[2,3,6-trihydroxy-5-(hydroxymethyl)-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C28H46O8 (510.3193)

(2z,6r)-6-[(1r,3as,5ar,9as,11r,11ar)-11-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C32H46O5 (510.3345)

(3e,5s,6r,8r,9r,10s,11s,12s,14r,16s,17e,19e)-12-ethyl-2,5,21,28-tetrahydroxy-11-methyl-7-oxa-22,27-diazapentacyclo[24.2.1.0⁶,⁸.0⁹,¹⁶.0¹⁰,¹⁴]nonacosa-1,3,17,19,21,27-hexaen-29-one

C29H38N2O6 (510.273)

(1'r,2r,2'r,4's,8'r,9'r,10'r,14's,15'r,17'r)-15',17'-dihydroxy-2',3,4,8',10',14',18',18'-octamethyl-5-oxo-5'-oxaspiro[furan-2,6'-pentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosane]-12',19'-diene-1'-carbaldehyde

methyl 3-[(1s,3r,4r,8s,9r,10s,11s,14r,15r)-9-hydroxy-11,15-dimethyl-14-[(2r)-1-(4-methylfuran-2-yl)propan-2-yl]-5-methylidene-6-oxo-7-oxapentacyclo[8.7.0.0¹,³.0⁴,⁸.0¹¹,¹⁵]heptadecan-3-yl]propanoate

C30H42N2O3S (510.2916)

(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-1-[(2r,3r,5s)-2,3,6-trihydroxy-5-(hydroxymethyl)-6-methylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C31H42O6 (510.2981)

(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1-[(2r,3r,5r)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C28H46O8 (510.3193)

ethyl 3-{5-[1-(2-hydroxy-4-methyl-5-oxofuran-2-yl)propan-2-yl]-2,4',5-trimethyl-5'-(prop-1-en-2-yl)-3',3'a,5',6'-tetrahydro-2'h-spiro[cyclopentane-1,1'-inden]-2-en-4'-yl}propanoate

C32H46O5 (510.3345)